Diabetes research information and news.
At the time of this post the Minimed 670g (artificial pancreas) came out about a week ago. The 670g is the first hybrid closed loop system ever. The new Minimed 670g insulin pump is now being shipped out to patients. The system uses SmartGuard HCL which is the most advanced algorithm to date. I currently…
Bionic Pancreas Critical Hurdle! Beta Bionics recently won $12 million in supplemental funding from the National Institutes of Health (NIH) to conduct a major multicenter, national clinical trials for the iLet™ (bionic pancreas). Developed by Edward Damiano (Beta Bionics) and Firas El-Khatib. They hope to have the device approved for market in about a year….
The Bionic Pancreas called “iLet” by Beta Bionics. The only fully integrated, fully automated, bihormonal bionic pancreas. The device uses both, insulin to lower blood sugar and glucagon to raise blood sugar for optimal glycemic control, a bridge to a cure. As I write this, the pump device is not yet available to the public. A…
Just a reminder that the MiniMed 670G hybrid closed loop System will be available to the public in the spring of 2017. We will let you know when it becomes available or are any updates with the system so please check back here often. Minimed 670g system available spring 2017, FDA approved. The Minimed…
Medical device maker Medtronic has won Food and Drug Administration (FDA) approval for the MiniMed 670G device. The “hybrid closed loop system” monitors and adjusts glucose and insulin levels in patients with type 1 diabetes. The first artificial pancreas approved of its kind for treating diabetes will hit the market in spring of 2017. The…
I’m a type 1 diabetic that uses the Continuous Glucose Monitoring System (CGMS) by Medtronic. I use the MiniMed 530G system with the Enlite Sensor to manage my diabetes, it’s been a winner for me! The new CGM System by Medtronic looks to be a Winner for Type 1 Diabetes! Check out the full article…
Diabetes Cure News! Johnson & Johnson is joining forces with biotech company ViaCyte to speed development of the first stem cell treatment that could fix and essentially cure the life-threatening hormonal disorder type 1 diabetes. ViaCyte has already begun testing the device in a small number of diabetic patients. If it works as well in…
Type 1 diabetes cure close to reality after scientists discovered a way to protect the new insulin-secreting cells from the body’s own immune system attacks. Back in 2014 Professor Doug Melton and scientists from Harvard Stem Cell Institute found a way to produce huge quantities of pancreatic beta cells. The insulin-secreting cells can be used…
DRI Successfully Transplants BioHub. Diabetes Research Institute has successfully transplanted their bioengineered mini-organ called the DRI BioHub into the omentum of the first patient (Wendy Peacock). A very close friend of mine contacted me with this exciting news. Her very young daughter lives with type 1 diabetes and is using pump therapy so this could possibly…